Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
Research and development expenses	$ 64,600	$ 117,597	$ 109,651
General and administrative expenses	53,183	77,500	70,263
Manufacturing services	3,532	0	0
Total operating expenses	121,315	195,097	179,914
Loss from operations	(121,315)	(195,097)	(179,914)
Other (expense) income:
Gain on sale of VOWST business	5,684	0	0
Interest income	3,967	7,301	3,058
Interest expense	0	(2,468)	(6,020)
Other (expense) income, net	(14,107)	134	(705)
Total other (expense) income, net	(4,456)	4,967	(3,667)
Net loss from continuing operations	(125,771)	(190,130)	(183,581)
Net income (loss) from discontinued operations, net of tax	125,907	76,406	(66,576)
Net income (loss)	$ 136	$ (113,724)	$ (250,157)
Net loss from continuing operations per share attributable to common stockholders, basic	$ (0.81)	$ (1.49)	$ (1.7)
Net loss from continuing operations per share attributable to common stockholders, diluted	(0.81)	(1.49)	(1.7)
Net income (loss) from discontinued operations per share attributable to common stockholders, diluted	0.81	0.6	(0.62)
Net income (loss) from discontinued operations per share attributable to common stockholders, basic	0.81	0.6	(0.62)
Net loss per share attributable to common stockholders, basic	0	(0.89)	(2.31)
Net loss per share attributable to common stockholders, diluted	$ 0	$ (0.89)	$ (2.31)
Weighted average common shares outstanding, basic	155,400,760	128,003,294	108,077,043
Weighted average common shares outstanding, diluted	155,400,760	128,003,294	108,077,043
Other comprehensive income:
Unrealized gain on investments, net of tax of $0	$ 0	$ 10	$ 49
Currency translation adjustment	0	2	(1)
Total other comprehensive income	0	12	48
Comprehensive income (loss)	$ 136	$ (113,712)	$ (250,109)